The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACER THERAPEUTICS INC | COM | 00444P108 | 2,360 | 109,270 | SH | SOLE | 109,270 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 4,122 | 61,000 | SH | Put | SOLE | 61,000 | 0 | 0 | |
ALIMERA SCIENCES INC | COM | 016259103 | 953 | 974,318 | SH | SOLE | 974,318 | 0 | 0 | ||
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 975 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 3,696 | 168,000 | SH | SOLE | 168,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 37,555 | 453,233 | SH | SOLE | 453,233 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 14,012 | 1,030,330 | SH | SOLE | 1,030,330 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 2,720 | 200,000 | SH | Call | SOLE | 0 | 0 | 0 | |
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 20,695 | 311,111 | SH | SOLE | 311,111 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 45,562 | 1,162,000 | SH | SOLE | 1,162,000 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 5,783 | 147,500 | SH | Call | SOLE | 0 | 0 | 0 | |
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 6,323 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 2,126 | 53,800 | SH | Call | SOLE | 0 | 0 | 0 | |
CAS MED SYS INC | COM PAR | 124769209 | 10,264 | 5,263,508 | SH | SOLE | 5,263,508 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 9,686 | 830,000 | SH | SOLE | 830,000 | 0 | 0 | ||
CHEMBIO DIAGNOSTICS INC | COM NEW | 163572209 | 22,539 | 2,030,533 | SH | SOLE | 2,030,533 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 4,830 | 345,000 | SH | SOLE | 345,000 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 700 | 50,000 | SH | Call | SOLE | 0 | 0 | 0 | |
CUTERA INC | COM | 232109108 | 4,232 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
DEUTSCHE BANK AG | NAMEN AKT | D18190898 | 1,593 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
EDITAS MEDICINE INC | COM | 28106W103 | 1,792 | 50,000 | SH | Call | SOLE | 0 | 0 | 0 | |
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 980 | 25,000 | SH | Put | SOLE | 25,000 | 0 | 0 | |
FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 2,610 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
FORTY SEVEN INC | COM | 34983P104 | 1,168 | 73,000 | SH | SOLE | 73,000 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 112,433 | 4,750,000 | SH | SOLE | 4,750,000 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | NOTE 5.750% 8/0 | 45780VAB8 | 3,022 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
INTEC PHARMA LTD JERUSALEM | SHS | M53644106 | 13,035 | 2,962,568 | SH | SOLE | 2,962,568 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 51,520 | 4,025,000 | SH | SOLE | 4,025,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 2,432 | 190,000 | SH | Call | SOLE | 0 | 0 | 0 | |
IRIDEX CORP | COM | 462684101 | 13,920 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
ISHARES TR | MSCI EMG MKT ETF | 464287234 | 6,500 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
KADMON HLDGS INC | COM | 48283N106 | 36,149 | 9,060,014 | SH | SOLE | 9,060,014 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 1,730 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 9,734 | 34,803 | SH | SOLE | 34,803 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 2,295 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
MANNKIND CORP | COM NEW | 56400P706 | 204 | 107,500 | SH | Put | SOLE | 107,500 | 0 | 0 | |
MEI PHARMA INC | COM NEW | 55279B202 | 3,468 | 880,087 | SH | SOLE | 880,087 | 0 | 0 | ||
OBSEVA SA | COM | H5861P103 | 6,424 | 424,300 | SH | SOLE | 424,300 | 0 | 0 | ||
ONCOBIOLOGICS INC | COM | 68235M105 | 25 | 29,082 | SH | SOLE | 29,082 | 0 | 0 | ||
ORASURE TECHNOLOGIES INC | COM | 68554V108 | 824 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
POLARITYTE INC | COM | 731094108 | 589 | 25,000 | SH | Put | SOLE | 25,000 | 0 | 0 | |
REGENERON PHARMACEUTICALS | COM | 75886F107 | 6,900 | 20,000 | SH | Put | SOLE | 20,000 | 0 | 0 | |
ROCKWELL MED INC | COM | 774374102 | 123 | 25,000 | SH | Put | SOLE | 25,000 | 0 | 0 | |
SAREPTA THERAPEUTICS INC | COM | 803607100 | 7,931 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 9,519 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 775 | 25,000 | SH | Put | SOLE | 25,000 | 0 | 0 | |
TESARO INC | COM | 881569107 | 2,224 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
TRANSENTERIX INC | COM NEW | 89366M201 | 109 | 25,000 | SH | Put | SOLE | 25,000 | 0 | 0 | |
VERACYTE INC | COM | 92337F107 | 24,846 | 2,660,210 | SH | SOLE | 2,660,210 | 0 | 0 | ||
VERICEL CORP | COM | 92346J108 | 1,844 | 190,055 | SH | SOLE | 190,055 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 10,345 | 1,495,000 | SH | SOLE | 1,495,000 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 7,118 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
VIVEVE MED INC | COM NEW | 92852W204 | 728 | 267,500 | SH | SOLE | 267,500 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 4,140 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
ZAFGEN INC | COM | 98885E103 | 2,558 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 4,884 | 110,500 | SH | SOLE | 110,500 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 3,647 | 82,500 | SH | Call | SOLE | 0 | 0 | 0 | |
ZOGENIX INC | COM NEW | 98978L204 | 1,989 | 45,000 | SH | Put | SOLE | 45,000 | 0 | 0 | |
ZYNERBA PHARMACEUTICALS INC | COM | 98986X109 | 487 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 |